NUTEK OIDO News
5 articles
growth-positive
Nutek: Austro-Israeli startup identifies remaining cancer cells using space technology
Holloid, a Vienna-based biotech startup, is revolutionizing the monitoring of bioprocesses with its innovative holographic microscopy technology. Founded in April 2022, the company aims to detect contaminants in liquids faster and more efficiently than traditional methods. Holloids technology is applied in various industries, including pharmaceuticals, food, environment, and chemistry. The startup has received significant funding from Austria Wirtschaftsservice, Österreichische Forschungsförderungsgesellschaft, and Wirtschaftsagentur Wien, which has been crucial for its research and development. Holloids customer base is international and confidential, with a focus on Europe. The company plans to launch a financing round in 2025 to further its growth and aims to become a leader in bioprocess monitoring.
InvestmentCustomers
growth-positive
With space technology know-how: Start-up Nutek provides real-time cancer diagnosis » Business world
Nutek, an Austrian-Israeli startup, has developed a hand scanner that can detect traces of cancer cells during tumor removal surgeries. The technology, derived from space technology expertise, uses hyperspectral imaging to identify cancerous tissues in real-time, potentially reducing the need for multiple surgeries. The product, known as the Rainbow Probe, is expected to be available by 2026 and is currently being tested in pilot projects at MedUni Graz. Nutek has already secured two million euros in funding and is seeking additional investors and strategic partners for production and distribution. The innovation promises to revolutionize surgical procedures by improving efficiency and reducing healthcare costs.
InvestmentPartners
Growth-Positive
Episode 27: Dov Cohen of Nutek Medical
Nutek Medical, an Israeli medical device startup co-founded by Dov Cohen, has developed a tool that can detect cancerous tissue in real time during surgery. This tool is designed to assist surgeons in the removal of cancerous tissue. The discussion between Dov and Avraham at the offices of JMB Davis Ben-David covered various topics including the inspiration behind the creation of the tool, the role of patents in the business, team building, funding, and market research.
InvestmentExpand
growth-positive
Scanner Hunts Tiny Cancerous Cells In Real Time During Surgery
Israeli startup NuTek, co-founded by engineer Dov Cohen, is developing the Rainbow Probe, a handheld scanner that can detect traces of cancer cells in real time during surgery. The device uses hyperspectral imaging technology to identify different tissue reactions to light, thereby revealing any remaining tumour cells. The technology is currently being tested in a pre-clinical trial in Austria in partnership with the Medical University of Graz. NuTek has received over $2 million in grants from the Austrian Research Promotion Agency and the European Space Agency business incubator center, as well as a $100,000 grant from the Merage Institute.
InvestmentPartners
growth-positive
NuTek awarded $100,000 prize from Merage Institute's '45+ Entrepreneurs' Competition'
NuTek Ltd., a developer of rainbow probes that can detect remaining cancer cells, won first place in the Merage 45+ Entrepreneurs’ Competition. The competition provides funding, exposure, and recognition for startups. As the winner, NuTek received a $100,000 prize and acceptance into the Merage Institute Innovation Bridge Program. The Merage Institute aims to bridge innovation and entrepreneurship between Israel and the U.S. through various initiatives. The 45+ competition has been running since 2014. NuTeks Founder and Chairman, Dov Cohen, has a strong background in electronics, computers, and management.
Investment
